(Q39829122)

15 September 2017

BMPRII is a direct target of miR-21. (English)

1 reference

15 September 2017

Wenming Qin

1

1 reference

15 September 2017

Botao Zhao

2

1 reference

15 September 2017

Yi Shi

3

1 reference

15 September 2017

Chengguo Yao

4

1 reference

15 September 2017

Li Jin

5

1 reference

15 September 2017

Youxin Jin

6

1 reference

15 September 2017

1 July 2009

1 reference

Acta Biochimica et Biophysica Sinica

15 September 2017

1 reference

15 September 2017

41

1 reference

15 September 2017

618-623

1 reference

15 September 2017

7

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

15 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Getting to the root of miRNA-mediated gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

MicroRNAs in organogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Control of cardiac excitability by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Role of microRNAs in vascular diseases, inflammation, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Regulation of bone morphogenetic protein signalling in human pulmonary vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Stem cell biology and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMP049

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMP049

1 reference

15 September 2017

1 reference